VUNO said in a filing on Feb. 4 that last year's operating loss fell 60.3% from a year earlier to 4.93537 billion won.
During the same period, revenue rose 34.7% to 34.84783 billion won, and net loss decreased 55.5% to 5.78156 billion won.
The company cited continued growth of the cardiac arrest prediction medical device "DeepCARS" and expansion of software-as-a-service (SaaS) revenue as the drivers of improved results. It also noted that streamlining management through the sale of some business units contributed to better profit and loss.
As of the end of last year, VUNO's total assets stood at 50.38944 billion won, about the same level as a year earlier, while total liabilities fell to 14.27697 billion won from a year ago. In contrast, total equity increased to 36.11247 billion won.